MedTrace Logo

The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

NCT06463379 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2024-06-17

No results posted yet for this study

Summary

Interventional phase 3 study aiming to unravel the value of pulse steroids in achieving remission or low disease activity in refractory active JIA

Conditions

  • Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)

Interventions

DRUG

Solumedrol

2 days pulse steroid injection 125 mg methylrednisolone

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06463379 on ClinicalTrials.gov